Treatment of intractable epistaxis in patients with nasopharyngeal cancer

Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the...

Full description

Saved in:
Bibliographic Details
Published inAnnals of medicine (Helsinki) Vol. 55; no. 1; p. 2200257
Main Authors Yang, Xiaojing, Ren, Hanru, Li, Minghua, Zhu, Yueqi, Zhang, Weitian, Fu, Jie
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 12.12.2023
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.Conclusion: A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy. Highlights The mortality rate for carotid blowout following radiotherapy for NPC is high. Radiation therapy and tumor condition are correlated with epistaxis in NPC. Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation. The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion. Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis.
AbstractList Aim:  To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC). Methods:  This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy. Results:  For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics. Conclusion:  A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy. Highlights The mortality rate for carotid blowout following radiotherapy for NPC is high. Radiation therapy and tumor condition are correlated with epistaxis in NPC. Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation. The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion. Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis.
AbstractAim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.Conclusion: A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy.HighlightsThe mortality rate for carotid blowout following radiotherapy for NPC is high.Radiation therapy and tumor condition are correlated with epistaxis in NPC.Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation.The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion.Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis.
Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.Conclusion: A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy. Highlights The mortality rate for carotid blowout following radiotherapy for NPC is high. Radiation therapy and tumor condition are correlated with epistaxis in NPC. Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation. The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion. Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis.
 To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).  This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.  For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.  A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy.HighlightsThe mortality rate for carotid blowout following radiotherapy for NPC is high.Radiation therapy and tumor condition are correlated with epistaxis in NPC.Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation.The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion.Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis.
Author Ren, Hanru
Zhu, Yueqi
Yang, Xiaojing
Fu, Jie
Li, Minghua
Zhang, Weitian
Author_xml – sequence: 1
  givenname: Xiaojing
  surname: Yang
  fullname: Yang, Xiaojing
  organization: Department of Radiation Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
– sequence: 2
  givenname: Hanru
  surname: Ren
  fullname: Ren, Hanru
  organization: Department of Orthopedics, Shanghai Pudong Hospital, Pudong Medical Center, Fudan University
– sequence: 3
  givenname: Minghua
  surname: Li
  fullname: Li, Minghua
  organization: Department of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
– sequence: 4
  givenname: Yueqi
  surname: Zhu
  fullname: Zhu, Yueqi
  organization: Department of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
– sequence: 5
  givenname: Weitian
  surname: Zhang
  fullname: Zhang, Weitian
  organization: Department of Otorhinolaryngology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
– sequence: 6
  givenname: Jie
  surname: Fu
  fullname: Fu, Jie
  organization: Department of Radiation Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37074291$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi1URLeFnwDKkUuW8WeSE6CKj5UqcSlny3HGu66SeLG9tP33OOy2ohdOlsbPvDOj54KczWFGQt5SWFNo4QM0reRtB2sGjK8ZA2CyeUFWlCtZM1BwRlYLUy_QOblI6RYK01B4Rc55A41gHV2RzU1EkyeccxVc5eccjc2mH7HCvU_Z3PtUqtXeZF-YVN35vKtmk8J-Z-LDvEUzVtbMFuNr8tKZMeGb03tJfn79cnP1vb7-8W1z9fm6tqLluZaoOgqyV9SicIAGqGBD-eqxkcIqxzgq7iR3VvacK-oGU-6gSnZM9ZbyS7I55g7B3Op99FNZRAfj9d9CiFttYvZ2RG0Uo12npAPaiabnpkMhmUQpWjkI25Ssj8es_aGfcLC43D8-C33-M_ud3obfmgJlICSUhPenhBh-HTBlPflkcRzNjOGQNGuBc77YKag8ojaGlCK6pzkU9OJUPzrVi1N9clr63v275FPXo8QCfDoCfnYhTuYuxHHQ2TyMIbpY5Pik-f9n_AHhRLIu
Cites_doi 10.1001/archotol.128.3.280
10.1016/j.ijrobp.2011.07.006
10.1055/s-0038-1676660
10.2147/CMAR.S283968
10.1016/j.asjsur.2022.02.058
10.1038/srep32883
10.1016/S0140-6736(19)30956-0
10.2307/3579031
10.1002/lary.24721
10.1016/j.ijrobp.2017.11.038
10.1016/j.oraloncology.2019.02.023
10.1002/hed.21558
10.1002/hed.25988
10.5603/FM.a2021.0124
10.1177/17085381211020927
10.1007/s00234-006-0127-7
10.1016/j.critrevonc.2020.103088
10.18632/oncotarget.15896
10.1177/2150135118817309
10.1002/hed.25018
10.1002/lary.29119
10.3389/fneur.2020.554988
10.1093/jrr/rrac012
10.21037/cco.2016.03.19
10.1002/(SICI)1097-0347(200005)22:3<215::AID-HED2>3.0.CO;2-B
10.1002/hed.20161
10.1002/hed.21585
10.1007/s11060-020-03462-3
10.1007/s10147-017-1143-9
10.1056/NEJMoa2118191
10.1001/jamaneurol.2018.4165
10.1016/j.ijrobp.2010.08.029
10.5455/medarh.2020.74.139-141
10.2147/CMAR.S183537
10.1158/1055-9965.EPI-20-1702
10.1177/0194599820963129
10.1055/s-0034-1395488
10.1002/hed.21091
10.1007/s00405-016-4339-0
10.3109/02841867809127916
10.1016/j.radcr.2022.03.070
10.1016/j.radonc.2009.10.018
10.1371/journal.pone.0073918
10.1016/j.wneu.2020.02.113
10.1002/cncr.33197
10.1016/j.ijrobp.2011.02.054
10.1080/00016480701813806
10.3389/fneur.2021.739222
10.3390/jcm11072011
10.1024/0301-1526/a000572
10.1038/s41598-021-87170-6
10.1007/s00405-021-07111-x
10.2147/OTT.S44214
10.1016/j.anl.2022.01.006
10.1002/hed.24645
10.1016/j.amjoto.2020.102860
10.1016/S0360-3016(02)02760-8
10.1002/cncr.28934
10.1186/1758-3284-1-13
10.1007/s00062-019-00867-0
ContentType Journal Article
Copyright 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023
2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s)
Copyright_xml – notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023
– notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s)
DBID 0YH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1080/07853890.2023.2200257
DatabaseName Taylor & Francis Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate X. Yang et al
EISSN 1365-2060
EndPage 2200257
ExternalDocumentID oai_doaj_org_article_a6219965f01947b3a9e4525e5485d4c7
10_1080_07853890_2023_2200257
37074291
2200257
Genre Oncology
Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
00X
03L
0R~
0YH
23M
36B
4.4
5GY
5RE
AAJNR
AALUX
AAPXX
ABBKH
ABLKL
ABUPF
ACENM
ACFUF
ACGEJ
ACGFS
ADCVX
ADFCX
ADRBQ
ADXPE
AENEX
AEOZL
AEYQI
AFKVX
AIJEM
AIRBT
AJWEG
ALIIL
ALMA_UNASSIGNED_HOLDINGS
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
CYYVM
DKSSO
EBD
EBS
EMB
EMOBN
F5P
GROUPED_DOAJ
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
O9-
OK1
P2P
RPM
SV3
TFDNU
TFL
TFW
V1S
WH7
~1N
.55
.GJ
34G
39C
3O-
53G
5VS
AALIY
AAORF
ABWCV
ABZEW
ADFZZ
AFFNX
AFLEI
AGYJP
AJVHN
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CZDIS
DRXRE
DWTOO
ECM
EIF
EJD
H13
JENTW
M44
M4Z
NPM
NUSFT
OVD
QQXMO
TDBHL
TEORI
X7M
ZGI
ZXP
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c483t-5e69105b61ce4f0ea0142d483be754c6f23e63f53fc5b3361fda078165926bc13
IEDL.DBID RPM
ISSN 0785-3890
IngestDate Tue Oct 22 15:15:38 EDT 2024
Tue Sep 17 21:30:50 EDT 2024
Sat Oct 05 05:31:01 EDT 2024
Fri Aug 23 02:08:16 EDT 2024
Sat Sep 28 08:19:48 EDT 2024
Tue Jul 04 18:16:34 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords radiotherapy
Nasopharyngeal cancer
covered stent
carotid blowout
epistaxis
Language English
License open-access: http://creativecommons.org/licenses/by-nc/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c483t-5e69105b61ce4f0ea0142d483be754c6f23e63f53fc5b3361fda078165926bc13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
These authors have made equal contributions.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120450/
PMID 37074291
PQID 2803332002
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10120450
pubmed_primary_37074291
informaworld_taylorfrancis_310_1080_07853890_2023_2200257
doaj_primary_oai_doaj_org_article_a6219965f01947b3a9e4525e5485d4c7
crossref_primary_10_1080_07853890_2023_2200257
proquest_miscellaneous_2803332002
PublicationCentury 2000
PublicationDate 2023-12-12
PublicationDateYYYYMMDD 2023-12-12
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-12
  day: 12
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Annals of medicine (Helsinki)
PublicationTitleAlternate Ann Med
PublicationYear 2023
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_3_52_1
e_1_3_3_71_1
Zhao ZY (e_1_3_3_41_1) 2020; 55
e_1_3_3_18_1
e_1_3_3_39_1
e_1_3_3_14_1
e_1_3_3_37_1
e_1_3_3_16_1
e_1_3_3_58_1
e_1_3_3_10_1
e_1_3_3_56_1
e_1_3_3_12_1
e_1_3_3_31_1
e_1_3_3_54_1
e_1_3_3_40_1
e_1_3_3_63_1
Sahan M (e_1_3_3_48_1) 2014; 165
e_1_3_3_7_1
e_1_3_3_9_1
e_1_3_3_29_1
e_1_3_3_25_1
Ay N (e_1_3_3_35_1) 2021; 2021
Lan G (e_1_3_3_50_1) 2016; 51
e_1_3_3_27_1
e_1_3_3_46_1
e_1_3_3_69_1
e_1_3_3_3_1
e_1_3_3_21_1
e_1_3_3_44_1
e_1_3_3_67_1
Tsai HM (e_1_3_3_49_1) 2002; 65
e_1_3_3_5_1
e_1_3_3_23_1
e_1_3_3_42_1
e_1_3_3_65_1
e_1_3_3_30_1
e_1_3_3_51_1
e_1_3_3_17_1
e_1_3_3_19_1
e_1_3_3_13_1
e_1_3_3_38_1
e_1_3_3_59_1
e_1_3_3_15_1
e_1_3_3_36_1
e_1_3_3_57_1
e_1_3_3_34_1
e_1_3_3_55_1
Gu Y (e_1_3_3_61_1) 2020; 3
e_1_3_3_11_1
e_1_3_3_32_1
e_1_3_3_53_1
e_1_3_3_62_1
He CC (e_1_3_3_70_1) 2012; 47
Wang H (e_1_3_3_60_1) 2022; 102
Wu P (e_1_3_3_33_1) 2021; 35
e_1_3_3_6_1
e_1_3_3_8_1
e_1_3_3_28_1
Yau S. (e_1_3_3_47_1) 2015; 44
e_1_3_3_24_1
e_1_3_3_26_1
e_1_3_3_68_1
e_1_3_3_2_1
e_1_3_3_20_1
e_1_3_3_45_1
e_1_3_3_66_1
e_1_3_3_4_1
e_1_3_3_22_1
e_1_3_3_43_1
e_1_3_3_64_1
References_xml – ident: e_1_3_3_13_1
  doi: 10.1001/archotol.128.3.280
– ident: e_1_3_3_21_1
  doi: 10.1016/j.ijrobp.2011.07.006
– ident: e_1_3_3_56_1
  doi: 10.1055/s-0038-1676660
– ident: e_1_3_3_46_1
  doi: 10.2147/CMAR.S283968
– ident: e_1_3_3_57_1
  doi: 10.1016/j.asjsur.2022.02.058
– ident: e_1_3_3_24_1
  doi: 10.1038/srep32883
– ident: e_1_3_3_34_1
  doi: 10.1016/S0140-6736(19)30956-0
– ident: e_1_3_3_45_1
  doi: 10.2307/3579031
– ident: e_1_3_3_43_1
  doi: 10.1002/lary.24721
– ident: e_1_3_3_29_1
  doi: 10.1016/j.ijrobp.2017.11.038
– ident: e_1_3_3_69_1
  doi: 10.1016/j.oraloncology.2019.02.023
– volume: 47
  start-page: 191
  issue: 3
  year: 2012
  ident: e_1_3_3_70_1
  article-title: Management of intractable epistaxis and bleeding points localization of post-therapy nasopharyngeal carcinoma
  publication-title: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  contributor:
    fullname: He CC
– ident: e_1_3_3_19_1
  doi: 10.1002/hed.21558
– ident: e_1_3_3_30_1
  doi: 10.1002/hed.25988
– ident: e_1_3_3_38_1
  doi: 10.5603/FM.a2021.0124
– ident: e_1_3_3_51_1
  doi: 10.1177/17085381211020927
– volume: 55
  start-page: 671
  issue: 7
  year: 2020
  ident: e_1_3_3_41_1
  article-title: [Evaluation and embolization strategy by ASITN/SIR grade for injured internal carotid artery of nasopharyngeal carcinoma]
  publication-title: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  contributor:
    fullname: Zhao ZY
– ident: e_1_3_3_59_1
  doi: 10.1007/s00234-006-0127-7
– ident: e_1_3_3_53_1
  doi: 10.1016/j.critrevonc.2020.103088
– ident: e_1_3_3_26_1
  doi: 10.18632/oncotarget.15896
– volume: 102
  start-page: 1119
  issue: 15
  year: 2022
  ident: e_1_3_3_60_1
  article-title: Willis covered stent for paraclinoid aneurysms:efficacy and mid-long-term follow-up results
  publication-title: Zhonghua Yi Xue Za Zhi
  contributor:
    fullname: Wang H
– ident: e_1_3_3_58_1
  doi: 10.1177/2150135118817309
– ident: e_1_3_3_62_1
  doi: 10.1002/hed.25018
– ident: e_1_3_3_36_1
  doi: 10.1002/lary.29119
– ident: e_1_3_3_66_1
  doi: 10.3389/fneur.2020.554988
– ident: e_1_3_3_31_1
  doi: 10.1093/jrr/rrac012
– volume: 2021
  start-page: 4270441
  year: 2021
  ident: e_1_3_3_35_1
  article-title: Nasopharyngeal coil dislocation of an embolized internal carotid artery pseudoaneurysm
  publication-title: Case Rep Otolaryngol
  contributor:
    fullname: Ay N
– ident: e_1_3_3_10_1
  doi: 10.21037/cco.2016.03.19
– ident: e_1_3_3_12_1
  doi: 10.1002/(SICI)1097-0347(200005)22:3<215::AID-HED2>3.0.CO;2-B
– ident: e_1_3_3_6_1
  doi: 10.1002/hed.20161
– volume: 65
  start-page: 529
  issue: 11
  year: 2002
  ident: e_1_3_3_49_1
  article-title: Transnasal sphenopalatine artery electrocautery for posterior epistaxis
  publication-title: Zhonghua Yi Xue Za Zhi
  contributor:
    fullname: Tsai HM
– ident: e_1_3_3_18_1
  doi: 10.1002/hed.21585
– ident: e_1_3_3_32_1
  doi: 10.1007/s11060-020-03462-3
– ident: e_1_3_3_25_1
  doi: 10.1007/s10147-017-1143-9
– ident: e_1_3_3_54_1
  doi: 10.1056/NEJMoa2118191
– ident: e_1_3_3_55_1
  doi: 10.1001/jamaneurol.2018.4165
– volume: 51
  start-page: 367
  issue: 5
  year: 2016
  ident: e_1_3_3_50_1
  article-title: The clinical experience of transnasal endoscopic approach for skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma
  publication-title: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  contributor:
    fullname: Lan G
– ident: e_1_3_3_9_1
  doi: 10.1016/j.ijrobp.2010.08.029
– ident: e_1_3_3_40_1
  doi: 10.5455/medarh.2020.74.139-141
– ident: e_1_3_3_42_1
  doi: 10.2147/CMAR.S183537
– volume: 165
  start-page: e24-7
  issue: 1
  year: 2014
  ident: e_1_3_3_48_1
  article-title: Is nasal packing required in epistaxis?
  publication-title: Clin Ter
  contributor:
    fullname: Sahan M
– ident: e_1_3_3_2_1
  doi: 10.1158/1055-9965.EPI-20-1702
– ident: e_1_3_3_37_1
  doi: 10.1177/0194599820963129
– ident: e_1_3_3_39_1
  doi: 10.1055/s-0034-1395488
– ident: e_1_3_3_15_1
  doi: 10.1002/hed.21091
– ident: e_1_3_3_28_1
  doi: 10.1007/s00405-016-4339-0
– ident: e_1_3_3_44_1
  doi: 10.3109/02841867809127916
– ident: e_1_3_3_63_1
  doi: 10.1016/j.radcr.2022.03.070
– ident: e_1_3_3_16_1
  doi: 10.1016/j.radonc.2009.10.018
– volume: 3
  start-page: 184
  issue: 4
  year: 2020
  ident: e_1_3_3_61_1
  article-title: Reconstructive treatment of symptomatic vertebral artery dissecting aneurysms with Willis covered stent: initial experience
  publication-title: J Interv Med
  contributor:
    fullname: Gu Y
– ident: e_1_3_3_22_1
  doi: 10.1371/journal.pone.0073918
– ident: e_1_3_3_67_1
  doi: 10.1016/j.wneu.2020.02.113
– ident: e_1_3_3_11_1
  doi: 10.1002/cncr.33197
– ident: e_1_3_3_20_1
  doi: 10.1016/j.ijrobp.2011.02.054
– volume: 35
  start-page: 448
  issue: 5
  year: 2021
  ident: e_1_3_3_33_1
  article-title: Extracranial/intracranial vascular bypass to control carotid artery blowout in postirradiated nasopharyngeal carcinoma patients
  publication-title: Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  contributor:
    fullname: Wu P
– ident: e_1_3_3_14_1
  doi: 10.1080/00016480701813806
– ident: e_1_3_3_65_1
  doi: 10.3389/fneur.2021.739222
– ident: e_1_3_3_52_1
  doi: 10.3390/jcm11072011
– ident: e_1_3_3_64_1
  doi: 10.1024/0301-1526/a000572
– ident: e_1_3_3_8_1
  doi: 10.1038/s41598-021-87170-6
– ident: e_1_3_3_3_1
  doi: 10.1007/s00405-021-07111-x
– ident: e_1_3_3_5_1
  doi: 10.2147/OTT.S44214
– ident: e_1_3_3_4_1
  doi: 10.1016/j.anl.2022.01.006
– ident: e_1_3_3_27_1
  doi: 10.1002/hed.24645
– ident: e_1_3_3_68_1
  doi: 10.1016/j.amjoto.2020.102860
– ident: e_1_3_3_7_1
  doi: 10.1016/S0360-3016(02)02760-8
– ident: e_1_3_3_23_1
  doi: 10.1002/cncr.28934
– volume: 44
  start-page: 653
  issue: 9
  year: 2015
  ident: e_1_3_3_47_1
  article-title: An update on epistaxis
  publication-title: Aust Fam Physician
  contributor:
    fullname: Yau S.
– ident: e_1_3_3_17_1
  doi: 10.1186/1758-3284-1-13
– ident: e_1_3_3_71_1
  doi: 10.1007/s00062-019-00867-0
SSID ssj0002710
Score 2.452521
SecondaryResourceType review_article
Snippet Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy...
 To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).  This review focuses on the anatomy and...
Aim:  To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC). Methods:  This review focuses on the anatomy...
AbstractAim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2200257
SubjectTerms Carotid Arteries
carotid blowout
covered stent
Embolization, Therapeutic - adverse effects
Embolization, Therapeutic - methods
epistaxis
Epistaxis - complications
Epistaxis - therapy
Humans
Nasopharyngeal cancer
Nasopharyngeal Carcinoma - complications
Nasopharyngeal Carcinoma - therapy
Nasopharyngeal Neoplasms - complications
Nasopharyngeal Neoplasms - radiotherapy
Oncology
radiotherapy
Review
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZlDyGX0jzaunmgQq_eWh5Jto5JyJIU0lMCuQlLltq9eJddB5p_nxk_wu5SyCVX2RhpPkvzSTP6hrEf6KGliLVINcg6xVXSp8ZInQpZ17J0ZVF6OtC_-61vHuSvR_W4UeqLcsJ6eeDecD8rnVOirIrIRWThoDKBQnEBmbaqpe_vkWdm3EwNa3BedDoE6P9Uii45G-_ukKo2tlHTlAqHT3NKUiDftOGVOvH-HenS_xHQ3TzKDcc0-8Q-DoySX_QjOWAfQnPI9u6GmPkRu70fc8n5IvI5fcO3dGGKhyWRx3_zNbbyQWB1zelkljcVlTeoVs_NH2SS3NO_sTpmD7Pr-6ubdCigkHpZQpuqoJENKKeFDzJmocL9UI4QgAuFkl7HHIKGqCB65QA0glaR-A-FWrXzAj6zSbNowlfGA5iSLsWZWIKMhXIiz0MGLoLJnNAhYdPRgHbZ62RYMcqPDha3ZHE7WDxhl2Tm15dJ5rprQPDtAL59C_yEmU2QbNudcsS-JImFNzrwfUTU4pSiOEnVhMXT2lLBLgB6K2FfeoRfuwkFHSYYkbByC_utcWw_aeZ_O9luUlJDAp19e4-Rn7B9Ggwl1oj8lE3a1VM4Q3rUuvNuJrwAeW8EwQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Taylor & Francis Open Access
  dbid: 0YH
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELYolVAviBZaFlpkJK5ZYo_txEdARVuk5bRIcLJix6Z7ya42QYJ_jyePFYta9dBjHMdyZjye8cz4G0LOooYWLJQsUSDKJO6SLtFaqISJshS5zbPcoUN_eqsmd-LmXg7ZhHWfVoln6NABRbR7NQp3YeshI-48arUopjodY-nvMcc0A5l9IB95JttIbfowWW_GPGsBCfCTBL8ZLvH8bZgN9dSi-L_DMP2TJfo-ofKNhrreI7u9aUkvurXwmWz56gvZmfbB833yazYkldNFoHMcwzV4c4r6JVqRz_M6ttIeabWm6KKlVYF1DorVS_UYTUrqcJGsDsjd9c_Z1STpKykkTuTQJNKraBZIq5jzIqS-iAcjHnkB1mdSOBU4eAVBQnDSAqjIvQJRgDDmqqxj8JVsV4vKHxLqQed4O06HHETIpGWc-xRsAJ1apvyIjAcCmmUHmGHYgEPaU9wgxU1P8RG5RDKvOyPedduwWD2aXnxMoTimS8sQLVKRWSi0x4Csj-ctWQoXB9FvmWSa1t0RutokBv4xgdOBoybKFgZMisovnmqDlbsAsNeIfOs4vJ4mZOhV0GxE8g3eb_zH5ptq_rvF70ZItWhJp0f_Melj8gkfMbGG8e9ku1k9-R_RPGrsSSsAr5q7Ats
  priority: 102
  providerName: Taylor & Francis
Title Treatment of intractable epistaxis in patients with nasopharyngeal cancer
URI https://www.tandfonline.com/doi/abs/10.1080/07853890.2023.2200257
https://www.ncbi.nlm.nih.gov/pubmed/37074291
https://search.proquest.com/docview/2803332002
https://pubmed.ncbi.nlm.nih.gov/PMC10120450
https://doaj.org/article/a6219965f01947b3a9e4525e5485d4c7
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfWPSBeEN90QGUkXpPGOdtJHmFiKkhFPGzSeLJixx6VWFq1mQT_PXduPK0TEhKvF8ey786-s333O8beo4WWInQi0yC7DHdJlzWN1JmQXSdrW1e1owv95Ve9uJBfLtXlEdMpFyYG7Tu7yvuf13m_-hFjKzfXbp7ixObflqeESYWuSDGfsAlqaDqjj_tvWUUMArR9KkNzXKS8HULURhqRcioanpcUoKCoDB9UdERsxIFxihj-9xBM_-aH3g-nvGOfzh6zR6NjyT_sJ_CEHfn-KXuwHJ_On7HP5ymknK8DX1EfbqC8Ke435EP-Wu2Qykec1R2nC1ret1TloN3-7q_QoeSOVGT7nF2cfTo_XWRjHYXMyRqGTHmNToGyWjgvQ-FbPBaVKAmwvlLS6VCC1xAUBKcsgEbZtYQBRC-u2joBL9hxv-79K8Y9NDXlxjWhBhkqZUVZ-gJsgKawQvspyxMDzWYPl2FEQiEdmW-I-WZk_pR9JDbfNia060hYb6_MKHPT6pKCpVVAf1RWFtrG03Osx9OW6qTDTpq7QjJDvOwI-8okBv4xgHdJogZXFj2XtL1f3-wM1e0CoFZT9nIv4dthJoWZsvpA9gfzOPyCyhzRu5Pynvz_r6_ZQ5oCRdWI8g07HrY3_i36RoOdsUnxfTGLNwuzuCz-AKhECJw
link.rule.ids 230,315,730,783,787,867,888,2109,27516,27938,27939,53806,53808,59477,59478
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RkNpeqgJ9bJ9G4pptnLGd-NhWRQtlOS0SPVmxY8Nesmg3SOXf48ljtYta9dBr_JAz47HH8_gG4Dje0IKHiicKRZXEU9IlWguVcFFVorBFXjgy6E8v1ORSnF3Jq41cGAqrpDd06IAi2rOahJuM0UNI3Jd4rUU51emYan-PM4ozkPkT2JNa5BTWlf6arE_jLG8RCWhIQmOGLJ6_TbN1P7Uw_o9ATP-kij6OqNy4ok5ewotet2Rfu82wDzu-PoCn0957fginsyGqnC0Cm9McrqHUKeZvSY38PV_Fr6yHWl0xstGyuqRCB-Xyvr6OOiVztEuWr-Dy5Mfs-yTpSykkThTYJNKrqBdIq7jzIqS-jC-jLDIDrc-lcCpk6BUGicFJi6gi-0qCASKnq7KO42vYrRe1fwvMoy4oPU6HAkXIpeVZ5lO0AXVqufIjGA8ENLcdYobhAxBpT3FDFDc9xUfwjci87kyA1-2HxfLa9PJjSpVRvLQMUSUVucVSe_LI-vjgkpVwcRK9ySTTtPaO0BUnMfiPBRwNHDVRuMhjUtZ-cbcyVLoLkXqN4E3H4fUyMSezguYjKLZ4v_Uf2y31_KYF8CZMtahKp-_-Y9Gf4dlkNj0356cXP9_Dc2qiKBuefYDdZnnnP0ZdqbGfWmF4ALOoBk8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BkSouFaWFLrRgpF6zxBnbiY_QdrUFWvXQSnCyYsdu95Jd7aYS_Hs8eay6FYgD1_ghZ8bjGc-MvwE4jhpa8FDxRKGoknhKukRroRIuqkoUtsgLRw79i0s1vRFfvsshm3DVp1XSHTp0QBHtWU3CvajCkBH3MWq1KKY6HVPp73FGaQYyfwrPpBY53b_SH9P1YZzlLSABDUlozPCI52_TbKinFsX_EYbpnyzRxwmVDzTU5AXs9KYl-9TthV144uuXsH3RB8_34Px6SCpn88BmNIdr6OUU8wuyIn_OVvEr65FWV4xctKwuqc5BufxV30aTkjnaJMt9uJmcXZ9Mk76SQuJEgU0ivYpmgbSKOy9C6st4McoiL9D6XAqnQoZeYZAYnLSIKnKvJBQgirkq6zi-gq16XvsDYB51Qa_jdChQhFxanmU-RRtQp5YrP4LxQECz6AAzDB9wSHuKG6K46Sk-gs9E5nVnwrtuP8yXt6YXH1OqjNKlZYgWqcgtltpTQNbH-5ashIuT6IdMMk3r7ghdbRKD_1jAh4GjJsoWBUzK2s_vV4YqdyFSrxG87ji8Xibm5FXQfATFBu83_mOzpZ7dtfjdBKkWLen0zX8s-j1sX51OzLfzy69v4Tm1UI4Nzw5hq1ne-6NoKTX2XSsLvwECJQV4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+intractable+epistaxis+in+patients+with+nasopharyngeal+cancer&rft.jtitle=Annals+of+medicine+%28Helsinki%29&rft.au=Yang%2C+Xiaojing&rft.au=Ren%2C+Hanru&rft.au=Li%2C+Minghua&rft.au=Zhu%2C+Yueqi&rft.date=2023-12-12&rft.eissn=1365-2060&rft.volume=55&rft.issue=1&rft.spage=2200257&rft_id=info:doi/10.1080%2F07853890.2023.2200257&rft_id=info%3Apmid%2F37074291&rft.externalDocID=37074291
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0785-3890&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0785-3890&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0785-3890&client=summon